As of 2025-07-18, the Fair Value of Indofarma Tbk PT (INAF.JK) is -493.11 IDR. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 126.00 IDR, the upside of Indofarma Tbk PT is -491.35%.
With the market price of 126.00 IDR and our fair value calculation, Indofarma Tbk PT (INAF.JK) is not a good investment. Investing in INAF.JK stocks now will result in a potential loss of 491.35%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 27.58 | -37,580.64 | -457,624.30 | -720,993.18 | -334,488.57 | -310,131.82 |
| YoY growth | -99.65% | -136,355.98% | -1,117.71% | -57.55% | 53.61% | -27,515.46% |
| Market Cap (mil) | 390,508.03 |
| P/E | |
| Forward P/E |
| EPS | -98.62 |
| Avg earnings growth rate | -27,515.46% |
| TTM earnings | -305,654.28 |